期刊文献+

瑞舒伐他汀部分恢复吗啡耐受大鼠的吗啡镇痛效能 被引量:8

Rosuvastatin partially restored the analgesic effect of morphine in rats with morphine tolerance
暂未订购
导出
摘要 目的探讨瑞舒伐他汀对吗啡耐受大鼠的吗啡镇痛效能的影响及其相关的分子机制。方法 48只♂SD大鼠随机分成6组(n=8):Ⅰ组为空白对照组;Ⅱ组为吗啡耐受组;Ⅲ组为10 mg.kg-1瑞舒伐他汀对照组;Ⅳ组、Ⅴ组、Ⅵ组分别为0.4、2、10 mg.kg-1瑞舒伐他汀处理组。Ⅱ、Ⅳ、Ⅴ、Ⅵ组皮下注射吗啡10 mg.kg-1,Ⅰ组和Ⅲ组皮下注射生理盐水,每天8∶00和16∶00各1次,连续10 d。d 6起,上午皮下注射前30 min,Ⅰ、Ⅱ组给予生理盐水灌胃,Ⅲ、Ⅳ、Ⅴ、Ⅵ组给予相应剂量的瑞舒伐他汀灌胃,连续5 d。d 6、11,测定大鼠基础热缩足潜伏期(PWTL)后,计算尾静脉注射吗啡30 min时各组大鼠的MPE值。d 11行为学检测后处死大鼠,留取腰5脊髓,比较各组脊髓内细胞外调节蛋白激酶(ERK)、磷酸化细胞外调节蛋白激酶(p-ERK)及星形胶质细胞表面标志物GFAP的表达水平。结果①d 6,6组的基础PWTL无明显差异。与Ⅰ组相比,Ⅱ、Ⅳ、Ⅴ和Ⅵ组MPE值明显降低(P<0.05)。d 11,6组的基础PWTL无差异。与Ⅰ组相比,Ⅱ、Ⅳ组尾静脉注射吗啡后30 min的MPE值明显降低(P<0.05);与Ⅱ组相比,Ⅴ、Ⅵ组的MPE值明显升高(P<0.05)。②d 11,6组大鼠腰5脊髓内总ERK表达水平差异无显著性。与Ⅰ组相比,Ⅱ、Ⅳ组腰5脊髓内p-ERK表达明显升高(P<0.05);与Ⅱ组相比,Ⅲ、Ⅴ、Ⅵ组腰5脊髓内p-ERK表达明显降低(P<0.05)。与Ⅰ组相比,Ⅱ组腰5脊髓内GFAP的荧光强度明显升高(P<0.05);与Ⅱ组相比,Ⅵ组腰5脊髓内GFAP的强度明显降低(P<0.05)。结论瑞舒伐他汀能够部分恢复吗啡耐受大鼠的吗啡镇痛效果,这可能与其抑制脊髓内ERK的磷酸化,减少星形胶质细胞活化有关。 Aim To explore the effect of rosuvastatinon the analgesic effect of morphine in rats with mor-phine tolerance and investigate possible the underlying mechanisms. Methods Forty-eight male SD rats were randomly divided into six groups( n = 8 ) :saline control group (group Ⅰ ), morphine tolerance group (group Ⅱ ), 10 nag · kg-1 rosuvastatin control group (group Ⅲ), 0.4 mg· kg -1 rosuvastatin treatment group (group Ⅳ ), 2 mg · kg-1 rosuvastatin treatment group (group Ⅴ ) and 10 nag·kg-1 rosuvastatin treatment group(group Ⅵ). Rats were treated with subcutaneous injections of either saline ( group Ⅰ , Ⅲ ) or 10 mg· kg l morphine ( group Ⅱ ,Ⅳ, Ⅴ , Ⅵ). The injections were given twice daily at 8 : 00 and 16 : 00 for 10 days. The oral gavage of either saline (group Ⅰ , Ⅱ ) or rosuvastatin ( 10,0. 4,2, 10 nag · kg -1 respectively for groupⅢ, Ⅳ, Ⅴ, Ⅵ) began on day 6 and lasted for 5 consecutive days. Basic Paw withdrawal thermal la- tency (PWTL) was assessed on day 6 and 11, after that morphine (4 mg· kg-1) was injected via tail vein to determine the percentage of maximal possible effect (% MPE) 30rain after the injection. Lumbar 5 spinal cord was obtained immediately after the behavioral tests to determine the expression of ERK and p-ERK. Re- suits On day 6, the basic PWTL was similar amongsix groups. Compared with group Ⅰ, group Ⅱ , Ⅳ, V and Ⅵ showed significant decrease of % MPE at 30rain. On day Ⅱ, there was no significant difference in the basic PWTL among six groups. Compared with group I , group Ⅱ and IV showed a significant differ- ence in the decrease of % MPE at 30rain. Compared with % MPE at 30min of group Ⅱ , group Ⅲ, V and Ⅵ showed a significant difference increase. The ex- pression of ERK in L5 spinal cord showed no significant difference among six groups. However, compared with group Ⅰ , the expression of p-ERK in group Ⅱ and IV was obviously increased. Compared with group Ⅱ , the expression of p-ERK in group Ⅲ, V and Ⅵ was obvi- ously decreased. Compared with group Ⅰ , the expres- sion of GFAP in group Ⅱ was obviously increased, Compared with group Ⅱ, the expression of GFAP in group Ⅵ were obviously decreased. Conclusion Ro- suvastatin partially restores the analgesic effect of mor- phine in rats with morphine tolerance possibly through inhibiting the phosphorylation of ERK and activation of astrocytes in the spinal cord.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第1期64-68,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 30901399)
关键词 吗啡耐受 神经炎症 胶质细胞 他汀 脊髓背角 胞外调节蛋白激酶 morphine tolerance nerve inflammation glial cells statins spinal dorsal cord ERK
  • 相关文献

参考文献1

二级参考文献2

共引文献9

同被引文献58

  • 1彭皓.内皮素系统与骨转移性癌痛[J].医学信息(医学与计算机应用),2014,0(12):632-632. 被引量:2
  • 2谭丽艳,齐亚灵,李洪源,徐海波.初诊老年肥胖2型糖尿病患者血清nesfatin-1及apelin水平与胰岛素抵抗的关系[J].中国老年学杂志,2014,34(8):2034-2035. 被引量:17
  • 3耿志宇,吴新民,贾乃光,徐铭军,孟冬祥,王雷,董经伟,董刚.硬膜外舒芬太尼分娩镇痛的效应 随机、多中心研究[J].中华麻醉学杂志,2006,26(11):1028-1031. 被引量:25
  • 4PAICE J A, FERRELL B. The management of cancer pain [ J]. CA Cancer JChin, 2011, 61 (3): 157-182.
  • 5LI W, LI Y, ZHU S, et al. Rosuvastatin attenuated the existing morphine tolerance in rats with I5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44 [J]. NeurosciLett, 2015, 584: 314-319.
  • 6LI Y, SHU Y, JI Q, et al, Attenuation of morphine analgesic tolerance by rosuvastatin in naive and morphine tolerance rats [ J]. Inflammation, 2015, 38 (1) : 134 - 141.
  • 7JIMENEZ ANDRADE J M, MANTYH P. Cancer pain: from the development of nonse models to human clinical trials [ M ] //KRUGERL, LIGHT A R. Translational pain research: from mouse to man. Boca Raton, FL: CRC Press, 2010: 414-420.
  • 8MANTYH P W. Bone cancer pain: from mechanism to therapy [ J] Curr Opin Support Palliat Care, 2014, 8 (2) : 83 -90.
  • 9LEONCINI M, TOSO A, MAIOLI M, et al. Early high - dose rosuvastatin for contrast - induced nephropathy prevention in acute coronary syndrome : results from the PRATO - ACS study ( protective effect of rosuvastatin and antiplatelet therapy on contrast - inducedacute kidney injury and myocardial damage in patients with acute coronary syndrome) [ J]. J Am Coll Cardiol, 2014, 63 (1): 71-79.
  • 10HAN Y, ZHU G, HAN L, et al. Short - term rosuvastatin therapyfor prevention of contrast - induced acute kidney injury in patients with diabetes and chronic kidney disease [ J]. J Am Coll Cardiol, 2014, 63 (1): 62-70.

引证文献8

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部